This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com.
Please tell us what format you need. It will help us if you say what assistive technology you use.
The review started in January 2011 and MHRA reviewed medical and scientific literature to assess:
whether there could be differences in the bioavailability (extent/rate of absorption) of levothyroxine between different tablet products and/or batches